Beam Therapeutics Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | 211,333.3% | 209,050.0% | 336,950.0% | 359,150.0% | 322,566.7% | 497,083.3% | 540,850.0% | 3,168,433.3% | 759,616.7% | 7,159.0% | -113.9% | 775.7% | 447.7% | 539.8% | 430.9% | 411.6% | 485.2% | 581.9% | 44.3% | 1,144.6% | 739.4% | 660.6% | 337.4% | 1,322.8% | 1,202.0% | 1,131.9% | 5.0% | 34.8% | – | – | |
| – | – | – | – | – | -211,233.3% | -208,950.0% | -336,850.0% | -359,050.0% | -322,466.7% | -496,983.3% | -540,750.0% | -3,168,333.3% | -759,516.7% | -7,059.0% | 213.9% | -675.7% | -347.7% | -439.8% | -330.9% | -311.6% | -385.2% | -481.9% | 55.7% | -1,044.6% | -639.4% | -560.6% | -237.4% | -1,222.8% | -1,102.0% | -1,031.9% | 95.0% | 65.2% | 100.0% | 18.9% | |
| – | – | – | – | – | 211,333.3% | 209,050.0% | 336,950.0% | 359,150.0% | 322,566.7% | 497,083.3% | 540,850.0% | 3,168,433.3% | 759,616.7% | 7,159.0% | 189.5% | 775.7% | 447.7% | 539.8% | 430.9% | 411.6% | 485.2% | 581.9% | 44.3% | 1,144.6% | 739.4% | 660.6% | 337.4% | 1,322.8% | 1,202.0% | 1,131.9% | 87.0% | 329.3% | 19,407.3% | 261.9% | |
| – | – | – | – | – | 82,950.0% | 91,450.0% | 102,666.7% | 113,533.3% | 115,616.7% | 125,033.3% | 139,233.3% | 171,216.7% | 223,383.3% | 2,067.4% | 34.8% | 228.3% | 144.5% | 138.1% | 113.2% | 97.0% | 122.6% | 147.8% | 13.7% | 360.6% | 251.7% | 185.8% | 95.3% | 374.0% | 317.3% | 275.7% | 23.3% | 108.5% | 6,519.8% | 76.7% | |
| – | – | – | – | – | 82,950.0% | 91,450.0% | 102,666.7% | 113,533.3% | 115,616.7% | 125,033.3% | 139,233.3% | 171,216.7% | 223,383.3% | 2,067.4% | 338.2% | 228.3% | 144.5% | 138.1% | 113.2% | 97.0% | 122.6% | 147.8% | 13.7% | 360.6% | 251.7% | 185.8% | 95.3% | 374.0% | 317.3% | 275.7% | 110.3% | 403.0% | 25,927.1% | 261.2% | |
| – | – | – | – | – | -294,183.3% | -300,400.0% | -439,516.7% | -472,583.3% | -438,083.3% | -622,016.7% | -679,983.3% | -3,339,550.0% | -982,900.0% | -9,126.3% | -124.3% | -904.0% | -492.2% | -577.9% | -444.1% | -408.7% | -507.8% | -629.7% | 42.0% | -1,405.3% | -891.1% | -746.4% | -332.7% | -1,596.9% | -1,419.2% | -1,307.6% | -15.3% | -337.8% | -25,827.1% | -242.3% | |
| – | – | – | – | – | – | 1,166.7% | 1,983.3% | 9,950.0% | 8,616.7% | 2,816.7% | 26,133.3% | 350.0% | 866.7% | 1.2% | 0.0% | 7.6% | 12.4% | 31.5% | 38.0% | 41.1% | 59.4% | 73.9% | 3.8% | – | 120.5% | 85.0% | – | – | 145.6% | 112.4% | 9.3% | 31.1% | 1,528.0% | 24.9% | |
| – | – | – | – | – | -297,683.3% | -316,750.0% | -464,166.7% | -507,633.3% | -570,300.0% | -574,200.0% | -1,591,066.7% | -3,359,333.3% | -1,270,883.3% | -3,685.2% | -126.7% | -820.8% | -432.1% | -678.3% | -186.4% | -398.5% | -411.5% | -558.9% | 45.6% | -1,331.6% | -773.1% | -677.5% | -300.5% | -1,462.8% | -1,208.3% | -1,162.4% | 214.1% | -297.2% | -25,036.3% | -54.7% | |
| – | – | – | – | – | 3,500.0% | 16,350.0% | 916.7% | 35,050.0% | 132,216.7% | -68,116.7% | 911,083.3% | 14,700.0% | 287,983.3% | -5,441.2% | -0.3% | -166.3% | -140.8% | 15.3% | 5.0% | -51.3% | -120.2% | -101.0% | 0.4% | 72.7% | 0.3% | -38.4% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -297,683.3% | -316,750.0% | -464,166.7% | -507,633.3% | -570,300.0% | -574,200.0% | -1,591,066.7% | -3,359,333.3% | -1,270,883.3% | -3,685.2% | -126.7% | -820.8% | -432.1% | -693.6% | -191.4% | -398.5% | -411.5% | -558.9% | 45.2% | -1,331.6% | -773.5% | -677.5% | -300.5% | -1,462.8% | -1,208.3% | -1,162.4% | 214.1% | -297.2% | -25,036.3% | -54.7% | |
| – | – | – | – | – | -279,883.3% | -285,266.7% | -422,816.7% | -454,250.0% | -419,000.0% | -601,716.7% | -658,783.3% | -3,316,250.0% | -1,242,200.0% | -3,455.8% | 184.3% | -781.6% | -411.6% | -656.3% | -166.7% | -379.3% | -387.6% | -528.7% | 47.3% | -1,258.3% | -725.8% | -639.1% | -282.4% | -1,388.8% | -1,142.8% | -1,105.1% | 228.4% | -279.5% | -25,513.9% | -38.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.